Wednesday, February 10, 2010, 12:28PM AEST - The Australian Stockmarket closes in 3 hours and 37 minutes.
To create a watchlist or portfolio of shares, Register

Watson Pharmaceuticals Inc. (WPI)

 8:04AM AEST: 38.10 USD  Up 0.41 (1.09%)  
 MORE ON WPI 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 WATSON PHARMACEUTCLS (NYSE:WPI) Delayed quote dataEdit
Last Trade:38.10 USD
Trade Time: 8:04AM AEST
Change:Up 0.41 (1.09%)
Prev Close:37.69
Open:37.95
Bid:N/A
Ask:N/A
1y Target Est:41.64
Day's Range:37.73 - 38.38
52wk Range:25.31 - 42.50
Volume:860,159
Avg Vol (3m):930,605
Market Cap:4.04B
P/E (ttm):19.64
EPS (ttm):1.94
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add WPI to Portfolio   Download Data

 HEADLINES 
•Iron Safety Hits AMAG Pharmaceuticals
at Seeking Alpha (Fri, Feb 5)
•Cephalon Enters Generics Market
Zacks.com (Wed, Feb 3)
•Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
PR Newswire (Wed, Feb 3)
•Watson signs deal for emergency contraceptive
AP (Tue, Feb 2)
•Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.
PR Newswire (Tue, Feb 2)
•Watson completes $15 million buyout of Eden
AP (Sat, Jan 30)
•Watson Completes Acquisition of Eden Biodesign
PR Newswire (Fri, Jan 29)
•The Biggest Growth Stocks in Health Care
at Minyanville.com (Fri, Jan 29)
•Improving Visibility on Watson
Zacks.com (Thu, Jan 28)
•There's Nothing Generic About the Profits
at Investopedia (Thu, Jan 28)
•UPDATE - Novartis optimistic on generic Lovenox approval
at Reuters (Tue, Jan 26)
•UPDATE - Novartis says on track with generic Lovenox
at Reuters (Sat, Jan 23)
•Watson Pharm downgraded by Needham
Briefing.com (Sat, Jan 23)
More Headlines for WPI...
 ANALYST 
EPS Est (next year) (Dec-09) :2.57
EPS Est (in 2 years) (Dec-10) :3.06
Avg Rec (current)*:2.5
PEG Ratio:1.92
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices